Carregant...
Somatostatin Receptor Subtype-4 Regulates mRNA Expression of Amyloid-Beta Degrading Enzymes and Microglia Mediators of Phagocytosis in Brains of 3xTg-AD Mice
Alzheimer’s disease (AD) is a progressive neurodegenerative disorder resulting in memory and cognitive impairment. The use of somatostatin receptor subtype-4 (SSTR(4)) agonists have been proposed for AD treatment. This study investigated the effects of selective SSTR(4) agonist NNC 26–9100 on mRNA e...
Guardat en:
| Publicat a: | Neurochem Res |
|---|---|
| Autors principals: | , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2019
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6894394/ https://ncbi.nlm.nih.gov/pubmed/31630317 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11064-019-02890-6 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|